Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery

Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.

In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.

 

whitepaper image
Vector-1

Download whitepaper

Scaling patient engagement strategies in precision medicine trials

As patient engagement continues to emerge as a powerful tool for enabling the success of precision medicine trials, the integration of genomic data within healthcare and the need to secure stakeholder investment in long-term relationship building strategies have never been more urgent. In March 2025, Sano hosted a discussion with key opinion leaders across the pharma and biotech sector to explore how they approach innovation in this breakthrough field.

In this whitepaper, “Scaling patient engagement strategies in precision medicine trials: Technology, integration, and regulatory development," we dive into the key discussion points and explore the solutions and approaches industry experts are developing to successfully scale the use of patient engagement strategies and make the integration of precision medicine into healthcare a global reality.
scaling whitepaper

 

What’s inside:

Patient-centric engagement: The importance of relationship building strategies, the critical role of patient voice and education, and how to accelerate adoption within industry 

Regulatory challenges: From investment hurdles to interoperability and standardization

Big data: Characterizing rare patient populations, data sharing frameworks and principles for cross-organizational collaboration

Cost challenges: From implementing wearables to investing in long term government strategies

Co-building frameworks: The power of collaboration and the impact of international investment and policy models

Download to learn more.